Published on IRCCS materno infantile Burlo Garofolo (https://www.burlo.trieste.it)

Home > Printer-friendly > In vivo anti-lymphoma activity of an agonistic human recombinant anti-TRAIL-R2 minibody.

In vivo anti-lymphoma activity of an agonistic human recombinant anti-TRAIL-R2 minibody. [1]

TitoloIn vivo anti-lymphoma activity of an agonistic human recombinant anti-TRAIL-R2 minibody.
Publication TypeJournal Article
AuthorsZauli, G [2], Corallini, F [3], Zorzet, S [4], Grill, V [5], Marzari, R [6], Secchiero, P [7]
PubMed ID20714918 [8]

Source URL: https://www.burlo.trieste.it/ricerca/pubblicazioni/vivo-anti-lymphoma-activity-agonistic-human-recombinant-anti-trail-r2-minibody#comment-0

Collegamenti
[1] https://www.burlo.trieste.it/ricerca/pubblicazioni/vivo-anti-lymphoma-activity-agonistic-human-recombinant-anti-trail-r2-minibody
[2] https://www.burlo.trieste.it/ricerca/biblio?f%5Bauthor%5D=104
[3] https://www.burlo.trieste.it/ricerca/biblio?f%5Bauthor%5D=99
[4] https://www.burlo.trieste.it/ricerca/biblio?f%5Bauthor%5D=774
[5] https://www.burlo.trieste.it/ricerca/biblio?f%5Bauthor%5D=775
[6] https://www.burlo.trieste.it/ricerca/biblio?f%5Bauthor%5D=232
[7] https://www.burlo.trieste.it/ricerca/biblio?f%5Bauthor%5D=98
[8] http://www.ncbi.nlm.nih.gov/pubmed/20714918?dopt=Abstract